[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635932":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":49,"collaborators":51,"id":55,"slug":18,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":78,"whyStopped":18,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment","EXPERIMENTAL","Food supplement to be taken once a day.",[13],"Dietary Supplement: Halophyte plant extracts",{"label":15,"type":16,"description":17,"interventionNames":18},"Clinical practice","NO_INTERVENTION","Without intervention",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DIETARY_SUPPLEMENT","Halophyte plant extracts","Dietary supplement based on halophyte plant extracts (experimental) plus regular medical treatment. Dosage: once daily. Duration of study: 3 months.",[9],[26],{"name":27,"affiliation":5,"role":28},"Soledad Pérez Sánchez","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"University Hospital Virgen Macarena","CONTACT","+34608114878","neurovascular.macarena@gmail.com",[36],{"facility":31,"status":18,"city":37,"state":18,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Seville","41009","Spain","ES",{"type":42,"coordinates":43},"Point",[44,45],-5.97317,37.38283,{"lat":45,"lon":44},[48],{"name":27,"role":32,"phone":33,"phoneExt":18,"email":34},{"type":50,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[52],{"name":53,"class":54},"Joan Montaner Villalonga","UNKNOWN","100635932",false,"NCT07559110","Supplementation With Salicornia Extract Rich in Polyphenols (B-Salicornia) to Improve Vascular Health in Patients With Dyslipidemia Who Are Not Candidates for Drug Treatment (Low to Moderate Risk)","Prospective, Randomized, Open-label, Parallel-Group Pilot Study Compared With Usual Medical Practice and Blinded Analysis (PROBE), to Evaluate the Effect and Safety of Administering a Food Supplement Based on Halophyte Plant Extracts in Patients With Newly Diagnosed Dyslipidemia Who do Not Have an Indication for Medical Treatment.","SALICOL","Inclusion Criteria:\n\n* Participants aged 40 to 65\n* Newly diagnosed dyslipidemia (two years) with SCORE ≥1 - \\\u003C5 (LDL 116 - \\\u003C190 mg\u002FdL): Moderate Risk\n* No indication for pharmacological treatment in primary prevention.\n* Possibility of performing analytical controls at the beginning\u002Fend of the study.\n* Willingness and capacity to give informed consent.\n\nExclusion Criteria:\n\n* Participants with vascular risk requiring pharmacological treatment or high\u002Fvery high vascular risk.\n* Participants in secondary prevention.\n* Hyperthyroidism according to the researcher's criteria.\n* Taking vitamin B supplements and\u002For supplements containing polyphenols in the 30 days prior to the screening visit (at the researcher's discretion).\n* Serious illness with a life expectancy of less than three months.\n* Known allergies or intolerance to halophytic plants.\n* Pregnant or breastfeeding women.\n* Presence of active neoplastic disease.\n* Having participated in another clinical trial with medicines in the 30 days prior to the screening visit, or intending to do so during your participation in this study.\n* Regular consumption of halophyte plants.\n* Participants who, in the researcher's opinion, are not able to comply with the study protocol.","ALL","40 Years","65 Years",{"count":66,"type":67},250,"ESTIMATED","INTERVENTIONAL",[70],"NA","The aim of this clinical trial is to evaluate the ability of a dietary supplement based on salicornia extracts and B vitamins (B-Salicornia) to modulate lipid levels in a population with newly diagnosed dyslipidemia who are not eligible for medical treatment.",[73],"Dyslipidemia",[75,76,77],"food supplement","polyphenol","Dyslipidaemia","NOT_YET_RECRUITING","2026-04-23",{"date":81,"type":82},"2026-04-30","ACTUAL",{"date":84,"type":67},"2026-05",{"date":86,"type":67},"2027-05",{"name":5,"class":6},1]